Hematologist, Associate Professor (tt) of Hematology, PI @waaralab HUH CCC & Uni Helsinki. Keen on patients, teaching, research. Germline, BMF, leukemias
What a #EHA2025, with multiple high-quality simultaneous publications!
Congrats @EHA_Hematology and all presenters!
Here are the most impressive malignant hematology studies🧵
Read a new review on the most frequent and severe infections in sickle cell disease, to facilitate their diagnosis and treatment, and theoretically also their prevention through well-defined public health measures.
https://t.co/3TO2TxQys2
📣 THE MAIN SCIENTIFIC TOPICS OF #ESHALL2025!
Register now ➡ https://t.co/w5UWiiKoQx
4th Translational Research Conference on ACUTE LYMPHOBLASTIC LEUKAEMIA
🗓️ May 22-24, 2025 - Malahide (Dublin) 🇮🇪
Chairs: Kathrin Bernt, @CoolsJn, @DombretHerve, @ullawk#ESHCONFERENCES#LEUsm
Wonderful and inspiring for the future the results of the COG AALL1731 study on blinatumomab in childhood ALL #ASH24
Next step👉 remodulation of CHT backbone
📣 HERE ARE THE CONFIRMED SPEAKERS FOR #ESHALL2025
Learn more ➡ https://t.co/w5UWiiKWG5
4th Translational Research Conference on ACUTE LYMPHOBLASTIC LEUKAEMIA
🗓️ May 22-24, 2025 - Malahide (Dublin) 🇮🇪
Chairs: Kathrin Bernt, @CoolsJn, @DombretHerve, @ullawk#ESHCONFERENCES#LEUsm
Today we are sharing our Clinical Guidelines & the impact they have made across the world.
To order or download a copy of the CGs or our One Pagers head to our website site today ➡️ https://t.co/K9UFPZ8Stb
#TBDawareness#TeamTelomere15
Finally out ➡️ A huge shout out for @MRLitzow@eaonc@MayoCancerCare
Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults | New England Journal of Medicine https://t.co/26exTImZdi
➡️ consolidation Blina improves OS in MRD-ve Ph-ve B-cell ALL
Vuonna 2022 Suomessa todettiin yhteensä 37 268 uutta #syöpä'ä, vuonna 2021 luku oli 36 543. Yli 320 000 syöpään sairastunutta suomalaista oli elossa vuoden 2022 lopussa.
👉 Tutustu @CancerRegFi Syöpä 2022 -raporttiin: https://t.co/hWFRHCOMME
MYCT1 controls environmental sensing in hematopoietic stem cells and its silencing compromises
HSC expansion. Brilliant work by Mikkola lab @UCLA
https://t.co/tsZ0L0klN8
FinnGen-tutkimus onnittelee tieteellistä johtajaamme Aarno Palotietä, jonka Helsingin yliopiston dosenttiyhdistys on nimittänyt vuoden dosentiksi!
@APalotie on suomalaisen genomitutkimuksen uranuurtaja ja tutkimusjohtaja @FIMM_UH@helsinkiuni . https://t.co/V6k8If69Mv
Unveiling the mechanism of genetic necrotizing fasciitis: https://t.co/SMvZ4TtiBX NFKB1truncations predispose carriers to excessive inflammation by disrupting two key immune pathways. Treatments targeting inflammasome and interferon signaling show therapeutic promise. Eklund lab
@AaronGoodman33 @AaronGoodman33 Why not including ERCC6L2 disease in this list? Causes BMF-> TP53-mutated MDS/AML (erythroid/M6). We have got information already on nearly 90 patients globally in a very short time! See also a stellar edtiorial @marrowgenes
https://t.co/3AXeiZ5Yem
Excellent review on Shwachman-Diamond syndrome that manifests as neutropenia (BM failure), exocrine pancreatic insufficiency, skeletal abnormalities, and, in 10-30% of cases, myeloid neoplasms. Caused by mutations in SBDS, DNAJC21, EFL1, or SRP54 genes.
https://t.co/ujyqgLLHyD
ASH offers an array of resources for clinicians treating & individuals living with #sicklecell disease. The Society's transformative, multi-faceted, patient-centric initiative strives to improve health outcomes for this population. Learn more: https://t.co/vyahnH9v6U 1/2 🧵
Allogeneic stem cell transplantation is the only potentially curative treatment for various blood cancers.
To cure, patients need YOU as donor of bone marrow or (much more frequently!) peripheral blood🙏
Register and be a real-world superhero!
Share and save lives🙏 #WMDD23